
A Lexington company received a multi-million dollar boost and more from Google’s venture capital arm.
SynapDx got a $15.4 million investment from Google Ventures in its efforts to come up with a blood test to diagnose autism, according to a report on Boston Inno. Along with the money, Google’s Andrew Conrad will join SynapDx’s board of directors.
The earliest autism can be diagnosed with a test is 4 ½ years of age, but SynapDX hopes to push that earlier.
Find out what's happening in Lexingtonfor free with the latest updates from Patch.
Read the entire Boston Inno story by clicking here.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.